Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Journal of Leukocyte Biology|June 11, 2015
Epigenetic regulation of IL-12-dependent T cell proliferationMatthew Schaller, Toshihiro Ito, Ronald M Allen, et al.Journal of Medicinal Chemistry|March 29, 2012
Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerasesSumandeep K Gill, Hao Xu, Paul D Kirchhoff, et al.Nature Chemical Biology|January 31, 2012
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemiaJolanta Grembecka, Shihan He, Aibin Shi, et al.Journal of Medicinal Chemistry|December 16, 2024
Structure-Based Development of Novel Spiro-Piperidine ASH1L InhibitorsGuang Huang, Rhiannon Stevens, Devon G Hucek, et al.Oncotarget|November 27, 2016
Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and meninLaurie K Svoboda, Natashay Bailey, Raelene A Van Noord, et al.Chembiochem : a European Journal of Chemical Biology|August 1, 2023
Garcinolic Acid Distinguishes Between GACKIX Domains and Modulates Interaction NetworksMeghan E Breen, Stephen T Joy, Omari J Baruti, et al.Molecular Cancer Therapeutics|September 11, 2013
A novel small-molecule inhibitor of mcl-1 blocks pancreatic cancer growth in vitro and in vivoFardokht Abulwerdi, Chenzhong Liao, Meilan Liu, et al.Plos One|November 9, 2013
Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypesNicolai A Kittan, Ronald M Allen, Abhay Dhaliwal, et al.Genome Biology|February 5, 2025
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylationRyan T Wagner, Ryan A Hlady, Xiaoyu Pan, et al.Cancer Discovery|December 1, 2022
Mutant NPM1 Hijacks Transcriptional Hubs to Maintain Pathogenic Gene Programs in Acute Myeloid LeukemiaXue Qing David Wang, Dandan Fan, Qinyu Han, et al.Pageof 10